Kaçar Ayşen Aydın, Aksay Ersin, Bayram Başak, Kıran Emre, Güldalı Bahar Elif
Department of Emergency Medicine, Turgutlu State Hospital, Manisa, Türkiye.
Department of Emergency Medicine, School of Medicine, Izmir Economy University, Kocaeli, Türkiye.
Turk J Emerg Med. 2024 Jul 1;24(3):158-164. doi: 10.4103/tjem.tjem_34_24. eCollection 2024 Jul-Sep.
Hyperlactatemia has been recognized as a significant prognostic indicator in critically ill patients. Nonetheless, there remains a gap in understanding the specific risk factors contributing to increased mortality among undifferentiated emergency department (ED) patients presenting with elevated lactate levels.
The objective of the study is to investigate potential risk factors for 30-day in-hospital mortality in ED patients with hyperlactatemia.
All nontraumatic adult presentations to the ED who had a lactate level of ≥2.5 mmol/L were included. Comorbidities, vital signs, lactate levels, lactate clearance, lactate normalization, and final diagnosis were compared with 30-day in-hospital mortality.
A 30-day in-hospital mortality rate of 10.4% was observed in 979 patients. The mortality rate was higher in hypotensive patients (odds ratio [OR] 4.973), in nursing home patients (OR 5.689), and bedridden patients (OR 3.879). The area under the curve for the second lactate level (0.804) was higher than the first lactate level (0.691), and lactate clearance (0.747) for in-hospital mortality. A second lactate level >3.15 mmol/l had a sensitivity of 81.3% in predicting in-hospital mortality. The OR for mortality was 6.679 in patients without lactate normalization. A higher mortality rate was observed in patients with acute renal failure (OR 4.305), septic shock (OR 4.110), and acute coronary syndrome (OR 2.303).
A second lactate measurement more accurately predicts in-hospital mortality than lactate clearance and the first lactate level in ED patients. Nursing home patients, bed-ridden patients, hypotensive patients on initial ED presentation, patients without lactate normalization, and patients with a final diagnosis of acute renal failure, septic shock, and acute coronary syndrome had a higher mortality rate.
高乳酸血症已被公认为危重症患者的一项重要预后指标。然而,对于急诊科(ED)中乳酸水平升高的未分化患者,导致死亡率增加的具体危险因素仍缺乏了解。
本研究旨在调查急诊科高乳酸血症患者30天院内死亡率的潜在危险因素。
纳入所有乳酸水平≥2.5 mmol/L的非创伤性成年急诊患者。将合并症、生命体征、乳酸水平、乳酸清除率、乳酸正常化情况及最终诊断与30天院内死亡率进行比较。
979例患者的30天院内死亡率为10.4%。低血压患者(比值比[OR]4.973)、疗养院患者(OR 5.689)及卧床患者(OR 3.879)的死亡率更高。第二次乳酸水平的曲线下面积(0.804)高于第一次乳酸水平(0.691),且乳酸清除率(0.747)对院内死亡率的预测作用也如此。第二次乳酸水平>3.15 mmol/L预测院内死亡率的敏感度为81.3%。乳酸未正常化的患者死亡率OR为6.679。急性肾衰竭患者(OR 4.305)、感染性休克患者(OR 4.110)及急性冠状动脉综合征患者(OR 2.303)的死亡率更高。
对于急诊科患者,第二次乳酸测量比乳酸清除率及首次乳酸水平更能准确预测院内死亡率。疗养院患者、卧床患者、急诊科初诊时低血压患者、乳酸未正常化的患者以及最终诊断为急性肾衰竭、感染性休克和急性冠状动脉综合征的患者死亡率更高。